Published in Cancer on April 01, 2004
Preventive screening of women who use complementary and alternative medicine providers. J Womens Health (Larchmt) (2009) 1.56
Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care (2008) 1.51
Naturopathic practice at north american academic institutions: description of 300,483 visits and comparison to conventional primary care. Integr Med Insights (2014) 1.42
Polypharmacy in older adults with cancer. Oncologist (2010) 1.23
Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual (2006) 1.19
Insurance coverage and subsequent utilization of complementary and alternative medicine providers. Am J Manag Care (2006) 1.19
The value of acupuncture in cancer care. Hematol Oncol Clin North Am (2008) 1.00
Use of Chinese medicine by cancer patients: a review of surveys. Chin Med (2011) 0.95
Acupuncture for nonpalliative radiation therapy-related fatigue: feasibility study. J Soc Integr Oncol (2009) 0.92
Out-Of-Pocket Expenditures on Complementary Health Approaches Associated With Painful Health Conditions in a Nationally Representative Adult Sample. J Pain (2015) 0.87
The effect of complementary and alternative medicine claims on risk adjustment. Med Care (2006) 0.86
Assessing and analyzing change in attitudes in the classroom. Assess Eval High Educ (2007) 0.77
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol (2006) 2.65
Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc (2003) 2.11
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85
Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med (2007) 1.64
Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutr (2002) 1.62
Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med (2005) 1.40
Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin Cancer Res (2010) 1.20
Quality of life at the end of life. Health Qual Life Outcomes (2007) 1.14
Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med (2004) 1.09
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN Oncol (2012) 1.08
Description of clinical risk factor changes during naturopathic care for type 2 diabetes. J Altern Complement Med (2009) 1.08
Elevated blood pressure during sleep and wake in children with sleep-disordered breathing. Pediatrics (2011) 1.06
Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2005) 1.05
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res (2011) 1.00
Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med (2013) 0.96
Use of complementary and alternative medicine (CAM) by Washington State hospices. Am J Hosp Palliat Care (2008) 0.96
Might massage or guided meditation provide "means to a better end"? Primary outcomes from an efficacy trial with patients at the end of life. J Palliat Care (2009) 0.95
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Res (2014) 0.95
Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J Clin Gastroenterol (2008) 0.92
Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med (2006) 0.92
Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis Rheum (2007) 0.92
Survival in HIV-1-positve adults practicing psychological or spiritual activities for one year. Altern Ther Health Med (2007) 0.91
MRI evaluation of metal acupuncture needles. Acupunct Med (2013) 0.86
Patterns of Weekday and Weekend Sedentary Behavior Among Older Adults. J Aging Phys Act (2014) 0.85
Evidence for correlations between distant intentionality and brain function in recipients: a functional magnetic resonance imaging analysis. J Altern Complement Med (2005) 0.84
Replicable functional magnetic resonance imaging evidence of correlated brain signals between physically and sensory isolated subjects. J Altern Complement Med (2005) 0.84
Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol (2011) 0.81
Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr A (2009) 0.78
Eating frequency and risk of colorectal cancer. Cancer Causes Control (2013) 0.78
Associations of soluble fiber, whole fruits/vegetables, and juice with plasma Beta-carotene concentrations in a free-living population of breast cancer survivors. Women Health (2012) 0.77
Nocturnal dipping is preserved in children with sleep disordered breathing regardless of its severity. Pediatr Pulmonol (2013) 0.77
Low Doses of Traditional Nanophytomedicines for Clinical Treatment: Manufacturing Processes and Nonlinear Response Patterns. J Nanosci Nanotechnol (2015) 0.76
Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther (2013) 0.75
Three lessons from a randomized trial of massage and meditation at end of life: patient benefit, outcome measure selection, and design of trials with terminally ill patients. Am J Hosp Palliat Care (2009) 0.75
No matter how well done, [corrected] HIV/AIDS CAM utilization papers in 2006 make us sad. J Altern Complement Med (2006) 0.75
Ankyloglossia in Infancy: An Indian Experience. Indian Pediatr (2017) 0.75
A survey of complementary and alternative medicine (CAM) awareness among neurosurgeons in Washington State. J Altern Complement Med (2009) 0.75